Cargando…
Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting
BACKGROUND: Despite intensive pharmacotherapy, a considerable number of patients with severe asthma have inadequate disease control. Patients with severe asthma who experience exacerbations consume significant health care resources. OBJECTIVE: To assess health care resource utilization and associate...
Autores principales: | Chastek, Benjamin, Korrer, Stephanie, Nagar, Saurabh P., Albers, Frank, Yancey, Steve, Ortega, Hector, Forshag, Mark, Dalal, Anand A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397901/ https://www.ncbi.nlm.nih.gov/pubmed/27348285 http://dx.doi.org/10.18553/jmcp.2016.22.7.848 |
Ejemplares similares
-
Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma
por: Dalal, Anand A., et al.
Publicado: (2016) -
Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
por: Ortega, Hector, et al.
Publicado: (2019) -
Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014) -
Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
por: Gibson, Peter G., et al.
Publicado: (2021) -
Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting
por: Stephenson, Judith J, et al.
Publicado: (2017)